Clowes M - Search Results

1

Mepolizumab for Treating Severe Eosinophilic Asthma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Bermejo I, Stevenson M, Cooper K, Harnan S, Hamilton J, Clowes M, Carroll C, Harrison T, Saha S. Bermejo I, et al. Among authors: clowes m. Pharmacoeconomics. 2018 Feb;36(2):131-144. doi: 10.1007/s40273-017-0571-8. Pharmacoeconomics. 2018. PMID: 28933002 Free article. Review.

2

Cabazitaxel for Hormone-Relapsed Metastatic Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Kearns B, Pandor A, Stevenson M, Hamilton J, Chambers D, Clowes M, Graham J, Kumar MS. Kearns B, et al. Among authors: clowes m. Pharmacoeconomics. 2017 Apr;35(4):415-424. doi: 10.1007/s40273-016-0457-1. Pharmacoeconomics. 2017. PMID: 27770303 Free article. Review.

3

Evolocumab for Treating Primary Hypercholesterolaemia and Mixed Dyslipidaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Carroll C, Tappenden P, Rafia R, Hamilton J, Chambers D, Clowes M, Durrington P, Qureshi N, Wierzbicki AS. Carroll C, et al. Among authors: clowes m. Pharmacoeconomics. 2016 Nov 16. doi: 10.1007/s40273-016-0472-2. Online ahead of print. Pharmacoeconomics. 2016. PMID: 27848220 Review.

4

Adalimumab for Treating Moderate-to-Severe Hidradenitis Suppurativa: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Tappenden P, Carroll C, Stevens JW, Rawdin A, Grimm S, Clowes M, Kaltenthaler E, Ingram JR, Collier F, Ghazavi M. Tappenden P, et al. Among authors: clowes m. Pharmacoeconomics. 2017 Aug;35(8):805-815. doi: 10.1007/s40273-017-0488-2. Pharmacoeconomics. 2017. PMID: 28176188 Free article. Review.

5

Evolocumab for Treating Primary Hypercholesterolaemia and Mixed Dyslipidaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Carroll C, Tappenden P, Rafia R, Hamilton J, Chambers D, Clowes M, Durrington P, Qureshi N, Wierzbicki AS. Carroll C, et al. Among authors: clowes m. Pharmacoeconomics. 2017 May;35(5):537-547. doi: 10.1007/s40273-017-0492-6. Pharmacoeconomics. 2017. PMID: 28285379 Free article. Review.

6

Certolizumab Pegol for Treating Rheumatoid Arthritis Following Inadequate Response to a TNF-α Inhibitor: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Bermejo I, Stevenson M, Archer R, Stevens JW, Goka E, Clowes M, Scott DL, Young A. Bermejo I, et al. Among authors: clowes m. Pharmacoeconomics. 2017 Nov;35(11):1141-1151. doi: 10.1007/s40273-017-0521-5. Pharmacoeconomics. 2017. PMID: 28550592 Free article. Review.

7

Pertuzumab for the Neoadjuvant Treatment of Early-Stage HER2-Positive Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Squires H, Pandor A, Thokala P, Stevens JW, Kaltenthaler E, Clowes M, Coleman R, Wyld L. Squires H, et al. Among authors: clowes m. Pharmacoeconomics. 2018 Jan;36(1):29-38. doi: 10.1007/s40273-017-0556-7. Pharmacoeconomics. 2018. PMID: 28770452 Free article. Review.

8

Obinutuzumab with Bendamustine for Treating Follicular Lymphoma Refractory to Rituximab: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Rafia R, Pandor A, Davis S, Stevens JW, Harnan S, Clowes M, Sorour Y, Cutting R. Rafia R, et al. Among authors: clowes m. Pharmacoeconomics. 2018 Oct;36(10):1143-1151. doi: 10.1007/s40273-018-0645-2. Pharmacoeconomics. 2018. PMID: 29594951 Free article. Review.

9

Sarilumab for Previously-Treated Moderate or Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Bermejo I, Ren S, Simpson E, Clowes M, Scott DL, Young A, Stevenson M. Bermejo I, et al. Among authors: clowes m. Pharmacoeconomics. 2018 Dec;36(12):1427-1437. doi: 10.1007/s40273-018-0677-7. Pharmacoeconomics. 2018. PMID: 29882210 Free article. Review.

10

Ibrutinib for Treating Relapsed or Refractory Mantle Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Tappenden P, Simpson E, Hamilton J, Pollard D, Clowes M, Kaltenthaler E, Meiklejohn D, Morley N. Tappenden P, et al. Among authors: clowes m. Pharmacoeconomics. 2019 Mar;37(3):333-343. doi: 10.1007/s40273-018-0713-7. Pharmacoeconomics. 2019. PMID: 30246228 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters